Clarify Health focuses on mapping patient journeys and using the data they get to improve outcomes. They are even using machine learning and cutting-edge technology to push their analytics platform to the next level. The result is powerful data that is turned into actionable insights quickly. And their success shows, with the company receiving additional funding to take its mission even further. You can read the official announcement below for more information.
Clarify Health, a leading cloud analytics and value-based payments platform company, announced today that it secured $ 150 million in Series D financing. SoftBank Vision Fund 2 led the round and was joined by funds and accounts managed by BlackRock and Memorial Hermann Health Systemalong with existing investors Insight Partners, Spark Capital, KKR, Aspenwood Ventures, Rivas Capitaland Sigmas Group.
Clarify is building healthcare’s system of intelligence, generating over 300 million annual patient journeys and 18 billion AI-powered predictions that empower providers, health plans, and life sciences companies to make better care decisions. The vast scale of the platform enables Clarify to apply the “Moneyball-style” analytical methods that predict outcomes in baseball to healthcare, objectively assessing the performance of hospitals and clinicians, and precisely identifying the right interventions and therapies for patients. Its scale creates the capability to pay for healthcare quality and outcomes more accurately and fairly. Following the company’s breakout year in 2021, with over 100% revenue growth and over 75 of healthcare’s largest and most influential organizations served, this latest investment will accelerate the expansion of Clarify’s intelligence offerings and the adoption of its value-based payments platform.
“Our mission is to fundamentally improve the way healthcare is paid for and delivered,” said Clarify Health CEO Jean Drouin, MD. shift to value. We finally have the AI-driven intelligence that healthcare organizations need to optimize every patient journey and embrace value-based arrangements across providers, payers, and life sciences. ”
Through its ability to serve insights that address fundamental business questions across payers, providers, and life sciences companies, Clarify is centered in a position of trust within the ecosystem of healthcare stakeholders — the key to enabling value-based payments. Clarify’s comprehensive platform connects clinical performance to financial incentives to deliver a transparent source of truth and enable the transaction of value-based payments. Its customers have been able to simplify contracts, make transparent performance, identify opportunities to improve care, and incentivize provider behavior change.
“With its actionable analytics, patient-level insights, and on-demand cloud technology, Clarify’s healthcare intelligence platform is helping make mission-critical care decisions to improve clinical and financial outcomes,” said Matt Singer, Managing Director, BlackRock. “Blue-chip organizations across the healthcare continuum are choosing to partner with Clarify because of their ability to deliver tangible ROI to their constituents. The demand for data and insight to drive better care and payment decisions continues to expand rapidly, and Clarify’s platform has the opportunity to make a strategic impact in addressing these societal challenges. ”
This newest round of funding comes on the heels of the company’s Series C funding in 2021 and two recent strategic acquisitions—Apervita’s Value Optimization Business and Embedded Healthcare—All driving expansion of the company’s value-based payments platform. This accelerated growth is a direct reflection of Clarify’s ability to deliver an exceptional customer experience and greater return on investment, validated by its 2021 Net Promoter Score that beats industry averages by over 40%. Clarify generates insights 30x faster than traditional methods with its patented automation processes for machine learning model generation and performance benchmarking. Its built-in, industry-leading grouper technology, patented case-mix adjustment methodology, and unprecedented ability to account for social determinants of health factors increase the precision and actionability of insights. Clarify has gained recent recognition for these achievements, including winning Frost & Sullivan’s 2022 North America Customer Value Leadership AwardCB Insights’ 2022 Digital Health 150and Black Book’s 50 top-rated emerging healthcare IT vendors. According to KLAS Research100% of the Clarify customers interviewed reported they would buy its platform again.
“We founded Clarify because we wanted healthcare organizations and patients to benefit from the big data efficiencies of the banking and consumer industries,” said Todd Gottula, President of Clarify Health. “Clarify’s enterprise intelligence system has unleashed an exchange of AI-driven insights among providers, health plans, and life sciences companies. Going forward, our value-based payments platform will enable the transaction of all payments, driving better care decisions, scaling value-based care, improving outcomes, and eliminating waste. ”
The original announcement can be found on Clarify Health’s official site.